Loading...
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
PURPOSE: Patients with uncontrolled asthma despite high doses of inhaled corticosteroid therapy plus another controller are defined as severe asthmatics. Tiotropium bromide respimat (TBR) is the only long-acting muscarinic antagonists (LAMA) approved for severe asthma. The aim of this study was to e...
Saved in:
| Published in: | J Asthma Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667506/ https://ncbi.nlm.nih.gov/pubmed/33204116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S274245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|